No Detail Found!

Spectroscopic interactions of non-insulin-dependent diabetes mellitus with levocetirizine

Author(s)
Shafaque Mehboob Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Sciences, Jinnah Sindh Medical University,Karachi,Pakistan
Moona Mehboob Department of Pharmaceutical Chemistry, School of Pharmacy, Dow University of Health Science,Karachi,Pakistan
Mehjabeen Department of Pharmacology, Faculty of Pharmaceutical Sciences, Federal Urdu University of Arts, Science and Technology, Karachi, Pakistan
SM Tariq Rafi Department of ENT, Jinnah Sindh Medical University,Karachi,Pakistan
Tariq Khan Department of Pharmacology, Faculty of Pharmaceutical Sciences, Federal Urdu University of Arts, Science and Technology, Karachi, Pakistan
Humaira Anser Department of Pharmacology, Institute of Pharmaceutical sciences, Jinnah Sindh Medical University,Karachi,Pakistan
Shaheen Perveen Department of Pharmaceutics, Institute of Pharmaceutical sciences, Jinnah Sindh Medical University,Karachi,Pakistan
Noor Jahan Department of Pharmacology, School of Pharmacy, Dow University of Health Science,Karachi,Pakistan
Asma Wazir Department of Pharmacognocy, Faculty of Pharmaceutical sciences, Jinnah University for Women,Karachi,Pakistan
Farah Owais Department of Pharmacology, Faculty of Pharmaceutical Sciences, Federal Urdu University of Arts, Science and Technology, Karachi, Pakistan
Abstract
Non insulin dependent diabetes mellitus (NIDDM) drugs such as glibenclamide and metformin is employed to heterogeneous disorder characterized by alteration in production of glucose due to impairment of both insulin secretion and insulin action. These patients might suffer with allergic rhinitis and in this case, there is a possibility to maintain patient on levocetirizine, an anti-allergic drug commonly used in rhinitis. The object of the present study is to detect possible interaction between glibenclamide or metformin with levocetirizine Current study was performed using UV spectroscopic technique sing simultaneous equation in pH simulated to gastric juice (pH 1), pH 4, pH 7.4 and in pH 9. All drugs followed Beer Lambert's Law. Results showed that glibenclamide and metformin can increase or decrease availability of levocetirizine and in the same way levocetirizine can alter availabilities of glibenclamide and metformin in different pH. Hence, drug interaction between glibenclamide or metformin with levocetirizne occurred. This may be due to his may be due to the charge transfer or binding capabilities of these drugs which resulted in significantly changed availability of NIDDIM as well as levocetirizine. Therefore, co-administration of these drugs should be avoided and furtherinvestigations at clinical and pre-clinical levels should be done.
Publication Details
Page(s) 1639-1644
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP4, Year: 2021

Request the full text from PASTIC

Keywords
levocetirizine, Non-insulin-dependent diabetes mellitus, drug interaction, Glibenclamide
References
Aftab K,Mehboob S,Khan AM,Sultana N,Arayne S N,Arayne MS,Sultana N,Rana MKZ .2004 .In vitro availability of glibenclamide in the presence of antacids. Pak. J. Pharm. Sci., 17(2) : 41-46.
Arayne MS,Sultana N,Zuberi MH .2009 .Spectroscopic quantification of metformin in bulk drug and pharmaceutical formulations using multivariate technique. Ind. J. Pharm. Sciences., 19(2) : 114-118.
Arayne MS,Sultana N,Hashim MZ,Haroon U .2010 .In vitro Studies of Interaction between Metformin and NSAIDs (Non steroidal antiinflammatory drugs) using spectrophotometry and RPhigh performance liquid chromatography. J. Chil. Chem. Soc, 55(2) : 206-11.
Arayne MS,Sultana N,Kamran Z,Afghan F Z .2006 .Synthesis and characterization of glibenclamide complex with magnecium, chromium, cobalt, nickel, zinc and cadmium salt. Pak. J. Pharm. Sci., 19(2) : 114-118.
Arayne MS,Sultana N,Zuberi MH,Haroon U .2010 .Invitro studies of interaction between metformin and NSAIDs using spectrophotometry and RP-HPLC. J. Chil. Chem. Soc., 55(2) : 206-211.
Arayne MS,Sultana N,Zuberi MH,Siddiqui FA,Haroon U .2013 .Simultaneous determination of metformin, captopril, lisinopril and enalapril by RPHPLC: its applications in dosage formulations and in human serum. Med. Chem. Res., 22(12) : 5717-5722.
Arayne MS,Sultana N,Zuberi MV,Siddiqui FA .2009 .Spectrophotometric quantitation of metformin in bulk drug and pharmaceutical formulations using multivariate technique. Indian J. Pharm. Sci., 71(3) : 33-335.
Avery GS .1973 .Checklist to potential clinically important interactions. Drugs, 5 : 187-190.
Pharmacopoea British .2010 .Her Majesty's Stationary Office. , 2 : 257-248.
Chen HH,Li SY,Chen W,Kao CH .2019 .Association between dipeptidyl peptidase-4 inhibitors and allergic rhinitis in Asian patients with diabetes. Int. J. Environ. Res. Public Health, 16(8) : 1323.
Devillier P Roche N and Faisy C .2008 .Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine. Clin. Pharmacokinet, 47(4) : 217-230.
Dhanya NB,Srinivas R,CR R .2008 .Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced wheal. Indian J. Dermatol. Ve, 74(5) : 475.
Elisabeth ASD,Renata PA,Maurilio JL,Alexandre CS,Marlrnr MF .2007 .Dissolution test for glibenclamide tablets. Quim. Nova, 30(5) : 1218-1221.
Hair PI,Scott LJ PI .2006 .. Levocetirizine. Drugs, 66(7) : 973-996.
Humphries TJ .1987 .A notable lack of drug interactions. Scand. J. Gastroenterol., 22(134) : 55-60.
Islam SI,Masuda QN,Bolagi OO .1996 .Possible interaction between cyclosporine and glibenclamide in post transplant diabetic patient. Ther Drug Monit., 18 : 624-626.
Jing Y,Ya Qin S,Zhuo-Rong L,Shao-Hong J .2007 .Development of RP-HPLC method for screening potentially counterfeit anti-diabetic drugs. J. Chromatogr. B, 835(1-2) : 254-259.
Jorissen M,Bertrand B,Stiels B,Vandenbulcke K B .2006 .Levocetirizine as treatment for symptoms of seasonal allergic rhinitis. , 2(2) : 55-62.
Kaleem Z,Khan JA,Mushtaq Z,Altaf S,Javed I .2018 .Assessment of potential interaction between simvastatin and clarithromycin in healthy adult male subjects. Pak. J. Pharm. Sci., 31(3) : 801-806.
Kubitza D,Becka M,Zuehlsdorf M,Mueck W .2006 .Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects. J. Clin. Pharmacol, 46(5) : 549-558.
Lee TK,Jeon YJ,Jung SJ .2021 .Bi-directional association between allergic rhinitis and diabetes mellitus from the national representative data of South Korea. Scientific Reports, 11(1) : 1-9.
Malasaki N,Yoichiro H,Yutaka M,Tadashi T,Makoto U .2003 .A case of sustained release hypoglycemia induced by taking glibenclamide and warfare. Japanese J. Stroke, 25(3) : 334-337.
Mehboob S,Aftab K,Khan MM,Sultana N,Arayne S N .2017 .Drug-drug interaction studies of levocetirizine with atenolol. J. Pharm. Pharmacol, 5 : 18-124.
Mehboob S,Parween S,Saleem D,Perveen S,Tabussum S S .2019 .In vitro interaction studies of levocetirizine with cimetidine. IJBPAS, 8(3) : 518-527.
Molimard M,Diquet B,Benedetti MS B .2004 .Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fund Clin. Pharmacol, 18(4) : 399-411.
Olen O,Neuman A,Koopmann B,Ludvigsson JF,Ballardini N,Westman M,Melen E,Kull I,Simren M,Bergstrom A .2014 .Allergy-related diseases and recurrent abdominal pain during childhood-a birth cohort study. Aliment Pharm Ther, 40 : 1349-1358.
Pletz MW,Preechachatchaval V,Bulitta J,Allewelt M,Burkhardt O,Lode H O .2003 .ABT-773: pharmacokinetics and interactions with ranitidine and sucralfate. , 47(3) : 1129-1131.
Riley TN,Deruiter J .2002 .Histamine and antihistamine agents. Wilson and Gisvold's Text Book of Organic Medicinal and Pharmaceutical Chemistry, 11 : 719-721.
SelfT H Tsiue SJ and Fowler JW .1989 .Interaction between rifampin and glyburide. Chest, 96(6) : 1443-1444.
Shapiro ET,Cauter EV,Tillil H,Given BD,Hirsch L,Beebe C,Rubenstein AH,Polonsky KS .1989 .Glyburide enhances the responsiveness of the β-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab., 69(3) : 571-576.
Speders S .1993 .Mofebutazone-evaluation of possible interaction with glibenclamide. Fortschritte der Medizin, 111 : 366-368.
Strolin Benedetti M,Whomsley R,Mathy FX,Jacques P.,Espie P,Canning M .2008 .Stereoselective renal tubular secretion of levocetirizine and dextrocetirizine, the two enantiomers of the H1-antihistamine cetirizine. Fund. Clin. Pharmacol, 22(1) : 19-23.
Tan GH,Nelson RL .1996 .Pharmacological treatment options for non-insulin dependent diabetes mellitus. Mayo Clin. Proc., 71 : 763-768.
Teichert J,Tuemmers T,Achenbach H,Preiss C,Hermann R,Ruus P,Preiss R .2005 .Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease. J. Clin. Pharmacol, 45(3) : 313-28.
Tripathi CB,Bhatt JD,Panchakshari UD,Hemavathi KG,Gulati OD .2002 .Interaction between H2 receptor blocker and neuromuscular blockers in vitro. Indian J. Pharmacol., 34 : 189-193.
Zhu S,Gao J,Shi Z,QLi G,Chen Z,Yao M .2015 .Inhibitory effect of Aristolochia fruit on Cytochrome P450 isozymes in vitro and in vivo. Pak. J. Pharm. Sci, 28(3) : 939-944.
Zuccaro P,Pacifici R,Pichini S,Vico V,Federzoni G,Pini LA,Sternieri E .1989 .Influence of antacid on bioavailability of glibenclamide. Drug Exp. Clin Res., 15(4) : 165-169.
0

Citations

0

Downloads

11

Views